LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all sufferers with CLL need therapy. In spite of all modern developments, the iwCLL nevertheless suggests watchful observation for clients with asymptomatic ailment.86 This recommendation is based on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).